[Preliminary evaluation of risk and effectiveness of early choline alphoscerate treatment in craniocerebral injury].


UNLABELLED Pharmacological treatment of craniocerebral injuries (CCI) to a large extent involves correction of metabolic disturbances resulting from primary and secondary mechanisms of trauma. Choline alphoscerate (CA), a substrate of phosphatydylocholine and a carrier of choline, plays a major role in phospholipidic transformation of the neuronal cell wall… (More)


  • Presentations referencing similar topics